GHCM
SRDX

Glen Harbor Capital Management’s Surmodics SRDX Stock Holding History

Glen Harbor Capital Management’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$61K Buy
1,344
+464
+53% +$20.2K ﹤0.01% 1219
2019
Q2 		$38K Buy
880
+320
+57% +$13.5K ﹤0.01% 1269
2019
Q1 		$24K Buy
+560
New +$28.5K ﹤0.01% 1265

Other funds holding SRDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Glen Harbor Capital Management's SRDX Position: Q3 2019 in Review

Glen Harbor Capital Management increased its Surmodics (SRDX) stake by 53% in Q3 2019, buying an estimated $20.2K and bringing the position to 1,344 shares worth $61K. The position accounts for ﹤0.01% of the portfolio, ranked #1219.

Glen Harbor Capital Management first reported a position in SRDX in Q1 2019 and has held it in 3 quarters since. 146 funds tracked by Wall St. Rank hold SRDX as of Q3 2019.

  • Glen Harbor Capital Management held 1,344 shares of Surmodics worth $61K as of Q3 2019.
  • Glen Harbor Capital Management bought 464 Surmodics shares in Q3 2019, an estimated $20.2K.
  • Surmodics made up ﹤0.01% of Glen Harbor Capital Management's portfolio in Q3 2019, its #1219 holding.
  • Glen Harbor Capital Management first reported a position in Surmodics in Q1 2019 and has held it in 3 quarters since.
  • 146 funds tracked by Wall St. Rank held Surmodics as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.